Skip to the page

Data / Drug companies / gamma-Aminobutyric Acid A Receptor Positive Modulator

gamma-Aminobutyric Acid A Receptor Positive Modulator drugs: 2 drugs from 33 companies in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

gamma-Aminobutyric Acid A Receptor Positive Modulator is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 111 products in this class from 33 companies, covering 2 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on June 23, 2026.

The request: Get every company that lists a gamma-Aminobutyric Acid A Receptor Positive Modulator drug in the FDA NDC directory, with headquarters, website and size. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 33Companies
  • 111Products
  • 2Drugs by generic name

Drugs in the gamma-Aminobutyric Acid A Receptor Positive Modulator class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Zolpidem tartrate10938
Zolpidem tartrate sublingual21

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Advanced Rx of Tennessee, LLC10tablet; tablet, film coatedGeneric drugs (ANDA)April 15, 2025
Bryant Ranch Prepack8tablet; tablet, extended releaseGeneric drugs (ANDA)September 24, 2020
NuCare Pharmaceuticals,Inc.8tablet; tablet, extended releaseGeneric drugs (ANDA)April 11, 2014
A-S Medication Solutions7tablet, film coated; tabletGeneric drugs (ANDA)September 5, 2007
Aphena Pharma Solutions - Tennessee, LLC7tablet; tablet, extended releaseGeneric drugs (ANDA)May 15, 2017
Bryant Ranch Prepack7tablet, extended release; tabletGeneric drugs (ANDA)September 24, 2020
Asclemed USA, Inc.6tablet, film coated; tablet, extended releaseGeneric drugs (ANDA)April 11, 2014
Preferred Pharmaceuticals Inc.6tablet, extended release; tabletGeneric drugs (ANDA)April 11, 2025
Cosette Pharmaceuticals, Inc.4tablet, film coated; tablet, coatedNew drug applications (NDA)February 7, 2025
Golden State Medical Supply, Inc.4tablet, coated; tablet, film coatedNew drug applications (NDA)April 23, 2007
Sandoz Inc4tablet, coated; tablet, extended releaseGeneric drugs (ANDA)October 31, 2011
St. Mary's Medical Park Pharmacy4tablet; tablet, coatedGeneric drugs (ANDA)August 28, 2024
Remedyrepack Inc.3tablet, film coated; tabletGeneric drugs (ANDA)December 8, 2023
Torrent Pharmaceuticals Limited3tablet; capsuleGeneric drugs (ANDA)June 23, 2026
Breckenridge Pharmaceutical, Inc.2tablet, extended releaseGeneric drugs (ANDA)May 18, 2026
Bryant Ranch Prepack2tablet, film coated, extended release; tabletGeneric drugs (ANDA)September 24, 2020
Chartwell RX, LLC2tabletGeneric drugs (ANDA)August 27, 2024
Direct RX2tabletGeneric drugs (ANDA)August 19, 2019
Lupin Pharmaceuticals, Inc.2tablet, extended releaseGeneric drugs (ANDA)April 11, 2014
Northwind Health Company, LLC2tablet, coated; tabletGeneric drugs (ANDA)May 20, 2025
PD-Rx Pharmaceuticals, Inc.2tablet, film coatedGeneric drugs (ANDA)May 4, 2007
Par Health USA, LLC2tabletGeneric drugs (ANDA)September 11, 2017
Proficient Rx LP2tablet, coatedGeneric drugs (ANDA)April 23, 2007
The Acme Laboratories Ltd.2tablet, film coatedGeneric drugs (ANDA)September 24, 2020
Viatris Specialty LLC2tabletNew drug applications (NDA)July 24, 2009
Almatica Pharma LLC1capsuleNew drug applications (NDA)May 9, 2023
American Health Packaging1tablet, film coatedGeneric drugs (ANDA)September 1, 2024
Calvin Scott & Co., Inc.1tabletGeneric drugs (ANDA)September 5, 2007
Cardinal Health 107, LLC1tabletGeneric drugs (ANDA)September 5, 2007
Direct_Rx1tablet, extended releaseGeneric drugs (ANDA)June 4, 2021
Major Pharmaceuticals1tabletGeneric drugs (ANDA)September 5, 2007
Quality Care Products, LLC1tabletGeneric drugs (ANDA)September 5, 2007
Umedica Laboratories USA Inc.1capsuleGeneric drugs (ANDA)May 14, 2026

Dosage forms

Dosage formProductsShare
Tablet4641.4%
Tablet, film coated2320.7%
Tablet, extended release2018%
Tablet, coated1513.5%
Tablet, film coated, extended release43.6%
Capsule32.7%

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.